Mariapia Vairetti

30PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jan 28, 2026
Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats.

Laura Giuseppina Di Pasqua, Sofia Lotti, Michelangelo Trucchi

|Nov 27, 2025
Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH.

Laura Giuseppina Di Pasqua, Giuseppina Palladini, Anna Cleta Croce

|Apr 27, 2024
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management.

Laura Giuseppina Di Pasqua, Murwan Mahmoud Abdallah, Fausto Feletti

|Apr 13, 2024
Innovative Molecular Targets and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 3.0.

Mariapia Vairetti, Giuseppe Colucci, Andrea Ferrigno

|Dec 23, 2023
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.

Giuseppina Palladini, Laura Giuseppina Di Pasqua, Anna Cleta Croce

|Oct 31, 2023
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH.

Laura G Di Pasqua, Marta Cagna, Giuseppina Palladini

Pageof 5